David J Lauffer

This inventor holds 89 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 18 EPO patents, primarily in DNA-PK Inhibitors (CPC class C07D471-04). Top assignees: Vertex Pharmaceuticals, Inc., Warner-Lambert Company, Merck Patent Gmbh. Active years: 1990-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Lauffer. Retrieved from https://idiyas.com/inventor/david-j-lauffer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 89 (Patent Applications = 13)

% Patents Active = 61.8

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 18 (Patent Applications = 29)

Average Co-Inventor Count = 6.4

ph-index = 23

Forward Citations = 1,624(Granted Patents)

Forward Citations (Not Self Cited) = 1,440(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Saline, MI (US) (1990 - 1996)
Stow, MA (US) (1994 - 2023)

Company Filing History:

82 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

6 out of 2,538

Warner-Lambert Company

4. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...

Areas of Expertise:

DNA-PK Inhibitors

Antiproliferation Compounds

c-MET Protein Kinase Inhibitors

Pteridinone Compounds

Quinoxaline Inhibitors

Benzooxadiazole Inhibitors

Azaindoles

Caspase Inhibitors

Pyrrolo[2,3-D]pyrimidines

Heterocyclic Inhibitors

Triazolothiadiazole

Pyrazole Inhibitors

89 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384790 - Pteridinone compounds and uses thereof (2025-08-12),

2. 12251387 - Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors (2025-03-18),

3. 12195453 - Antiproliferation compounds and uses thereof (2025-01-14),

4. 11813267 - DNA-PK inhibitors (2023-11-14),

5. 11572364 - Pteridinone compounds and uses thereof (2023-02-07),

6. 11440907 - Antiproliferation compounds and uses thereof (2022-09-13),

7. 11059826 - Pteridinone compounds and uses thereof (2021-07-13),

8. 11021465 - DNA-PK inhibitors (2021-06-01),

9. 11008305 - DNA-PK inhibitors (2021-05-18),

10. 10973830 - Substituted quinoxaline DNA-PK inhibitors (2021-04-13),

11. 10815225 - Antiproliferation compounds and uses thereof (2020-10-27),

12. 10786512 - DNA-PK inhibitors (2020-09-29),

13. 10501439 - DNA-PK inhibitors (2019-12-10),

14. 10442791 - DNA-PK inhibitors (2019-10-15),

15. 10391095 - DNA-PK inhibitors (2019-08-27),

Title: The Innovative Journey of David J Lauffer

Introduction: David J Lauffer, a talented inventor hailing from Stow, MA (US), has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents: David J Lauffer holds several patents in various industries, showcasing his versatility and expertise in inventing groundbreaking solutions to complex problems.

Career Highlights: Throughout his career, David J Lauffer has demonstrated a keen eye for identifying gaps in the market and developing unique inventions to address them. His innovative spirit has led to the creation of revolutionary products that have had a lasting impact on the industry.

Collaborations: David J Lauffer has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, David J Lauffer stands as a shining example of an inventor who has consistently pushed the boundaries of innovation. His passion for creating solutions that make a difference sets him apart in the world of inventions.

Profile summary based on public USPTO records.